University of California San Francisco

Neil Mehta, MD

Mehta
Neil
Mehta
MD

Associate Professor of Medicine

General Hepatology and Liver Transplantation

Department of Medicine

Address

400 Parnassus Avenue, #A740
San Francisco, CA 94143
United States

Biography

Dr. Neil Mehta is a gastroenterologist and specialist in liver transplantation.

In his research, Mehta examines liver cancer treatment, particularly as related to liver transplants. He has contributed to important publications in this area. His other research interests include outcomes for patients who undergo liver transplantation and cardiac iron overload in patients with chronic liver disease. He frequently lectures in the community and at the university on these subjects.

At the UCSF School of Medicine, Mehta supervises the training of residents as well as fellows in both gastroenterology and liver transplant medicine. He also delivers lectures on liver disease to UCSF medical students studying metabolism and nutrition.

Mehta earned his medical degree at UCSF and completed a residency in internal medicine at the University of Pennsylvania. He completed fellowships in gastroenterology and liver transplantation at UCSF.

Education

Institution Degree Dept or School End Date
University of California, San Francisco M.D. Medicine 2006

Board Certifications

American Board of Internal Medicine
American Board of Internal Medicine - Gastroenterology
American Board of Internal Medicine - Transplant Hepatology

Collaboration Interests

I am interested in:

  • policy change

Clinical Expertise

Alcoholic Liver Disease

Autoimmune Hepatitis

Cirrhosis

Drug-Induced Hepatitis

Fulminant Hepatic Failure

Hemochromatosis

Hepatitis B

Hepatitis C

Hepatocellular Carcinoma (Liver Cancer)

Liver Transplantation

Living Donor Liver Transplantation

Nonalcoholic Fatty Liver Disease

Polycystic Liver Disease

Primary Biliary Cirrhosis

Primary Sclerosing Cholangitis

Program Affiliations

UCSF Liver Center

In the News

Mignote Yilma, M.D. to Join National Clinician Scholars Program at UCSF
December, 16, 2020 | UCSF General Surgery Residency Program
Study Shows Excellent Post-Transplant Outcomes Following Down-Staging of HCC Patients
December, 10, 2014 | UCSF Transplant Surgery

Research Narrative

Dr. Mehta is engaged in research investigating clinical outcomes in patients with end-stage liver disease. His research focuses on two main areas:

  • Understanding issues related to the diagnosis and management of patients with hepatocellular carcinoma (HCC) particularly with regards to outcomes in liver transplantation. Specific topics we are currently interested in are evaluating the risk of HCC recurrence post-transplant based on transplant waiting times, creating an HCC recurrence risk score, and downstaging tumors in to conventional transplant criteria.
  • Understanding the role of iron overload in patients listed for liver transplant, specifically with regards to both hepatic and cardiac iron deposition.

Mr. Mehta is also conducting research related to the diagnosis and management of patients with hepatocellular carcinoma (HCC) particularly with regards to outcomes in liver transplantation.This includes a multicenter project with CPMC and Scripps to understand the role of downstaging tumors into conventional transplant criteria. He is also pursuing projects to address the risk of HCC recurrence post-transplant based on transplant waiting times as well as to create an HCC recurrence risk score. These projects are being done collaboratively with the Mayo clinic in Rochester and Jacksonville.

Dr. Mehta is also pursuing research to help optimize the management of iron overload in patients listed for liver transplant, specifically with regards to both hepatic and cardiac iron deposition.

Research Interests

Hepatocellular carcinoma (HCC)

Liver transplantation outcomes including expanded criteria liver transplants

Cardiopulmonary complications of chronic liver disease

Liver injury and repair (Liver transplantation)

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. Cost-Effectiveness Analysis of Resection, Ablation and Radiation Segmentectomy for Solitary Hepatocellular Carcinoma ≤ 3 cm from a United States Payor's Perspective.
    Wu X, Vakil P, Sarwar A, Faiz Z, Heller M, Lehrman E, Fidelman N, Mehta N, Lokken RP| | PubMed
  2. A call for clarity: a unified checklist for reporting use of large language models in writing scientific manuscripts.
    Mehta N, Felder RM, Kodish E, Imrey PB, Frankel RM| | PubMed
  3. Using locally-hosted Small Language Models (SLMs) to protect student, patient and research subject data in Health Professions Education.
    Masters K, Valanci-Aroesty S, Benjamin J, Mehta N, MacNeill H| | PubMed
  4. The 3C model: a simple prompt engineering framework for generative artificial intelligence.
    Damania R, Hrdy M, Mehta N, Wolbrink T| | PubMed
  5. Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multi-site Conjoint Analysis.
    Kao KD, Troost JP, Yang JD, Salgia R, Woolen SA, Mehta N, Hoteit MA, Jalal PK, El Dahan KS, Daher D, Quirk L, Patel N, Nayak A, Gamez J, Alsudaney M, Hernandez P, Bhongade M, Singal AG, Parikh ND| | PubMed
  6. Economic Burden of Recurrence in Early-Stage Hepatocellular Carcinoma Treated with Surgical Resection or Local Ablation in the United States: A Retrospective Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
    Mehta N, Wang L, Kamble S, Song Y, Gao E, Siegel A, Lax A, Sundaresan S, Zhang A, Wei V, Malhotra U| | PubMed
  7. Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinoma.
    Kim NG, Yao FY, Kwong AJ, Mehta N| | PubMed
  8. Social drivers of differences in hepatocellular carcinoma (HCC) stage of diagnosis, treatment, and survival in a large, integrated health care system.
    Yilma M, Houhong Xu R, Tucker LS, Saxena V, Voelkel J, Muzzin M, Lee J, Mehta N, Mukhtar N| | PubMed
  9. Patients who underwent TIPS face increases in hernia incarceration rates compared to patients managed with paracentesis: An analysis of prevalence and risk factors.
    Vissa A, Far AT, Lai JC, Mehta NJ, Kolli KP, Ge J| | PubMed
  10. Not Replaced, but Reinvented: AI Education Pathways to Prepare Future Physicians to Lead Healthcare Transformation.
    Mehta N, Mehta S, Rubenstein A, Wood SK| | PubMed